Patients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at Vulvar Site

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Patients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at Vulvar Site trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingPhase 3

NCT07431502

Trial to Evaluate Nonavalent HPV Vaccine as a Secondary Prevention in Patients Treated for Human Papilloma Virus Related…

Randomized, placebo-controlled phase 3 trial to evaluate nonavalent HPV vaccine as a secondary prevention in patients treated for human papilloma virus related…

Location not specified984 participantsStarted 2026-05

Treatment: HPV vaccine, Placebo vaccine